engleski

Health and socioeconomic aspects of population aging: role of personalized medicine

Rapid population aging presents many developed countries with challenges related to fiscal sustainability. European countries are particularly affected i.e., already in 2020, the proportion of persons aged 65 and above was above 20 percent in 19 countries. The change in disease patterns due to the aging population will reshape provision of healthcare services and health systems. A key question is whether population aging will run concurrently with the extension of life years spent in good health or whether we shall witness increased morbidity periods in old age. The SHARE study data reveals a strong association between age health status and healthcare utilization, thus supporting our concerns concerning the aging population and health systems’ ability to sustain future demand. In addition, large allocations for social protection and care are likely to limit investment in medicine and/or ethical, legal or issues connected with large sets of data ; we focus on that and on how objective health measures contribute to our understanding of the aging process education, which could cause adverse consequences in the long run, particularly for competitiveness of the labor force and economic development. Efficient personal medicine can contribute to successful education and therefore achievement of high employability of the labor force. The P4 (predictive, preventive, personalized and participatory) medicine has a great potential in containing the expansion of healthcare costs that have been fostered for decades by population aging. However, there are pending challenges related to strategies and technologies that will enable P4 medicine, for example, technological, ethical, legal or issues connected with large sets of data ; we focus on that and on how objective health measures contribute to our understanding of the aging process

Population aging ; health ; socioeconomic aspects ; personalized medicine

nije evidentirano